women s health medical abortion care

💊 MTP Kit (Mifepristone & Misoprostol Tablets) 🔹 Product Overview Product Name: MTP Kit Composition: Mifepristone 200 mg – 1 tablet Misoprostol 200 mcg – 4 tablets Category: Gynecology / Reproductive Healthcare Description: MTP Kit is a pharmaceutical combination used for the medical termination of early intrauterine pregnancy. It contains two active ingredients: Mifepristone (200 mg) and Misoprostol (200 mcg tablets), which work together to safely and effectively end early pregnancy under medical supervision. Mifepristone acts by blocking progesterone, a hormone essential for maintaining pregnancy, while Misoprostol induces uterine contractions to expel pregnancy tissue. This combination therapy is widely used in clinical practice and offers a non-surgical alternative for early pregnancy termination. The kit is indicated for use up to 63–70 days (9–10 weeks) of gestation and should be administered strictly as per prescribed medical guidelines. It is supplied in a convenient blister pack with clear dosage instructions. MTP Kit is a prescription-only medication and must be used under the guidance of a qualified healthcare professional to ensure safety and effectiveness. 🔹 Mechanism of Action Mifepristone blocks progesterone, a hormone necessary to sustain pregnancy Misoprostol induces uterine contractions, leading to expulsion 🔹 Indication Medical termination of pregnancy up to 63–70 days (9–10 weeks) gestation To be used strictly as per medical guidelines and prescription 🔹 Dosage & Administration Day 1: Mifepristone administered orally After 24–48 hours: Misoprostol administered as directed 🔹 Efficacy Approximately 95–98% success rate in early pregnancy when used correctly 🔹 Safety Profile Common Effects: Abdominal cramping Vaginal bleeding Nausea, vomiting Fever, fatigue Serious (Require Medical Attention): Excessive bleeding Infection Incomplete abortion Contraindications Suspected or confirmed ectopic pregnancy Chronic adrenal failure Bleeding disorders or anticoagulant therapy Hypersensitivity to active ingredients 🔹 Packaging 1 × Mifepristone tablet 4 × Misoprostol tablets Blister pack with instruction leaflet 🔹 Storage Store below 25–30°C Protect from moisture and direct sunlight 🚀 Why Choose Pratibha Pharma WHO-GMP certified manufacturing Export-compliant packaging & documentation Reliable bulk supply capability Private labeling & custom branding available Strong quality assurance with COA & regulatory support 📦 Supply Capability Bulk export orders Regulatory documentation support Stable manufacturing & timely delivery Long-term contract supply available 📞 Business Inquiry: Pratibha Pharma invites global distributors, healthcare institutions, and importers for bulk procurement and strategic partnerships. We ensure consistent quality, regulatory compliance, and reliable international supply.

💊 MTP Kit (Mifepristone & Misoprostol Tablets) 🔹 Product Overview Product Name: MTP Kit Composition: Mifepristone 200 mg – 1 tablet Misoprostol 200 mcg – 4 tablets Category: Gynecology / Reproductive Healthcare Description: MTP Kit is a pharmaceutical combination used for the medical termination of early intrauterine pregnancy. It contains two active ingredients: Mifepristone (200 mg) and Misoprostol (200 mcg tablets), which work together to safely and effectively end early pregnancy under medical supervision. Mifepristone acts by blocking progesterone, a hormone essential for maintaining pregnancy, while Misoprostol induces uterine contractions to expel pregnancy tissue. This combination therapy is widely used in clinical practice and offers a non-surgical alternative for early pregnancy termination. The kit is indicated for use up to 63–70 days (9–10 weeks) of gestation and should be administered strictly as per prescribed medical guidelines. It is supplied in a convenient blister pack with clear dosage instructions. MTP Kit is a prescription-only medication and must be used under the guidance of a qualified healthcare professional to ensure safety and effectiveness. 🔹 Mechanism of Action Mifepristone blocks progesterone, a hormone necessary to sustain pregnancy Misoprostol induces uterine contractions, leading to expulsion 🔹 Indication Medical termination of pregnancy up to 63–70 days (9–10 weeks) gestation To be used strictly as per medical guidelines and prescription 🔹 Dosage & Administration Day 1: Mifepristone administered orally After 24–48 hours: Misoprostol administered as directed 🔹 Efficacy Approximately 95–98% success rate in early pregnancy when used correctly 🔹 Safety Profile Common Effects: Abdominal cramping Vaginal bleeding Nausea, vomiting Fever, fatigue Serious (Require Medical Attention): Excessive bleeding Infection Incomplete abortion Contraindications Suspected or confirmed ectopic pregnancy Chronic adrenal failure Bleeding disorders or anticoagulant therapy Hypersensitivity to active ingredients 🔹 Packaging 1 × Mifepristone tablet 4 × Misoprostol tablets Blister pack with instruction leaflet 🔹 Storage Store below 25–30°C Protect from moisture and direct sunlight 🚀 Why Choose Pratibha Pharma WHO-GMP certified manufacturing Export-compliant packaging & documentation Reliable bulk supply capability Private labeling & custom branding available Strong quality assurance with COA & regulatory support 📦 Supply Capability Bulk export orders Regulatory documentation support Stable manufacturing & timely delivery Long-term contract supply available 📞 Business Inquiry: Pratibha Pharma invites global distributors, healthcare institutions, and importers for bulk procurement and strategic partnerships. We ensure consistent quality, regulatory compliance, and reliable international supply.